Position in RPRX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,679,225,155
+$477,354,656 QoQ
Shares Held
35,005,736
+12.5% QoQ
Ownership
6.08%
of shares outstanding
% of Portfolio
0.42%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Capital International Investors holds $7,233,634,148 across 15 Biotechnology names. RPRX ranks #2 (23.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,126,077 | $2,288,998,423 | |
| 2 | RPRX |
Royalty Pharma plc
This page
|
35,005,736 | $1,679,225,155 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
4,158,726 | $1,235,016,860 | |
| 4 | INSM |
INSMED Inc
|
5,595,194 | $914,926,122 | |
| 5 | ASND |
Ascendis Pharma A/S
|
1,958,843 | $448,046,159 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
2,674,727 | $155,535,375 | |
| 7 | RAPP |
Rapport Therapeutics, Inc.
|
3,097,973 | $96,935,575 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,338,803 | $88,240,505 |
All Filings in RPRX
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,679,225,155 | 35,005,736 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,201,870,499 | 31,104,309 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $960,063,844 | 27,212,694 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $788,358,738 | 21,880,620 | Shares | Defined | 2025-08-13 | |
| 2023-03-31 | $138,043,504 | 3,831,349 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $151,407,443 | 3,831,160 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $200,833,381 | 4,998,342 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $209,973,278 | 4,994,607 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $194,550,266 | 4,993,590 | Shares | Defined | 2022-05-19 | |
| 2021-12-31 | $198,803,361 | 4,988,792 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $180,247,057 | 4,987,467 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $694,481,600 | 16,942,708 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $717,509,785 | 16,449,101 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $823,390,217 | 16,451,353 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $436,435,989 | 10,374,043 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $395,054,020 | 8,137,055 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||